Wellington Shields Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-4,000
Closed -$397K 273
2019
Q3
$397K Hold
4,000
0.06% 197
2019
Q2
$370K Hold
4,000
0.06% 212
2019
Q1
$377K Sell
4,000
-1,700
-30% -$149K 0.06% 210
2018
Q4
$365K Sell
5,700
-5,700
-50% -$421K 0.07% 203
2018
Q3
$1.02M Hold
11,400
0.16% 131
2018
Q2
$905K Sell
11,400
-21,150
-65% -$1.76M 0.15% 137
2018
Q1
$2.9M Sell
32,550
-2,800
-8% -$269K 0.44% 50
2017
Q4
$3.69M Sell
35,350
-240
-0.7% -$27.1K 0.57% 36
2017
Q3
$5.19M Sell
35,590
-400
-1% -$54.5K 0.85% 17
2017
Q2
$4.67M Buy
35,990
+2,300
+7% +$282K 0.76% 25
2017
Q1
$4.19M Buy
33,690
+4,790
+17% +$573K 0.68% 29
2016
Q4
$3.35M Buy
28,900
+22,400
+345% +$2.49M 0.55% 38
2016
Q3
$679K Hold
6,500
0.12% 170
2016
Q2
$641K Sell
6,500
-1,700
-21% -$176K 0.11% 164
2016
Q1
$821K Sell
8,200
-6,300
-43% -$649K 0.14% 136
2015
Q4
$1.74M Buy
14,500
+350
+2% +$40.5K 0.29% 69
2015
Q3
$1.53M Buy
14,150
+1,550
+12% +$192K 0.26% 70
2015
Q2
$1.46M Sell
12,600
-700
-5% -$80K 0.22% 91
2015
Q1
$1.53M Buy
13,300
+1,300
+11% +$155K 0.23% 90
2014
Q4
$1.34M Buy
12,000
+3,300
+38% +$348K 0.21% 97
2014
Q3
$825K Hold
8,700
0.14% 152
2014
Q2
$747K Sell
8,700
-200
-2% -$15.2K 0.12% 169
2014
Q1
$621K Hold
8,900
0.11% 179
2013
Q4
$752K Hold
8,900
0.14% 150
2013
Q3
$686K Hold
8,900
0.13% 150
2013
Q2
$521K Buy
+8,900
New +$536K 0.09% 189

Other funds holding CELG

Wellington Shields Capital Management's CELG Position: Q4 2019 in Review

Wellington Shields Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,000 shares — an estimated $397K sold.

Wellington Shields Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $5.19M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Wellington Shields Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Wellington Shields Capital Management sold 4,000 Celgene Corp shares in Q4 2019, an estimated $397K.
  • Wellington Shields Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Wellington Shields Capital Management's Celgene Corp position peaked at $5.19M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Wellington Shields Capital Management's 13F filing for Q4 2019, filed 11 Feb 2020.